Self-Service Login / Register | bluecrossnepastore.com
Powered by Google

Utilization Management Criteria

Adjust type sizesmallmediumlarge

By Drug Name:

UMC-530-0170ABRAXANE PRIOR AUTHORIZATION CRITERIA
UMC-530-0047ABSTRAL PRIOR AUTHORIZATION CRITERIA
UMC-530-0133ACANYA STEP THERAPY CRITERIA
UMC-530-0027ACIPHEX SPRINKLES STEP THERAPY CRITERIA
UMC-530-0093ACTEMRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0147ACTHAR H.P. GEL PRIOR AUTHORIZATION CRITERIA
UMC-530-0108ACTICLATE PRIOR  AUTHORIZATION CRITERIA
UMC-530-0047ACTIQ PRIOR AUTHORIZATION CRITERIA
UMC-530-0205ADAGEN PRIOR AUTHORIZATION CRITERIA
UMC-530-0149ADDERALL STEP THERAPY CRITERIA
UMC-530-0181ADEMPAS PRIOR AUTHORIZATION/STEP THERAPY CRITERIA
UMC-530-0108ADOXA PRIOR AUTHORIZATION CRITERIA
UMC-530-0089AFINITOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0019ALDURAZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0173ALIMTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0108ALODOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0206ALOXI (PALONOSETRON) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0038ALTOPREV STEP THERAPY CRITERIA
UMC-530-0045ALVESCO STEP THERAPY CRITERIA
UMC-530-0098AMPYRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0022ANADROL-50 PRIOR AUTHORIZATION CRITERIA
UMC-530-0036ANZEMET STEP THERAPY CRITERIA
UMC-530-0039APRISO STEP THERAPY CRITERIA
UMC-530-0072ARCALYST PRIOR AUTHORIZATION CRITERIA
UMC-530-0092ARZERRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0113AUBAGIO PRIOR AUTHORIZATION CRITERIA
UMC-530-0200AVASTIN (bevacizumab) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0108AVIDOXY PRIOR AUTHORIZATION CRITERIA
UMC-530-0106AVONEX STEP THERAPY CRITERIA
UMC-530-0094AZOR STEP PRIOR AUTHORIZATION CRITERIA
UMC-530-0044BECONASE AQ STEP THERAPY CRITERIA
UMC-530-0081BELSOMRA STEP THERAPY CRITERIA
UMC-530-0083BENICAR HCT STEP THERAPY CRITERIA
UMC-530-0201BELEODAQ PRIOR AUTHORIZATION CRITERIA
UMC-530-0082BENICAR STEP THERAPY CRITERIA
UMC-530-0125BENLYSTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0133BENZACLIN STEP THERAPY CRITERIA
UMC-530-0076BERINERT PRIOR AUTHORIZATION CRITERIA
UMC-530-0060BONIVA PRIOR AUTHORIZATION CRITERIA
UMC-530-0067BOSULIF PRIOR AUTHORIZATION CRITERIA
UMC-530-0048BOTOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0054BRINTELLIX STEP THERAPY CRITERIA
UMC-530-0054BRISDELLE STEP THERAPY CRITERIA
UMC-530-0172BUPRENORPHINE-NALOXONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0130BUTRANS PRIOR AUTHORIZATION CRITERIA
UMC-530-0052BYDUREON STEP THERAPY CRITERIA
UMC-530-0052BYETTA STEP THERAPY CRITERIA
UMC-530-0115CAMBIA STEP THERAPY CRITERIA
UMC-530-0120CAPRELSA PRIOR AUTHORIZATION CRITERIA
UMC-530-0209CARBOPLATIN (PARAPLATIN) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0011CEREDASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0011CERDELGA PRIOR AUTHORIZATION CRITERIA
UMC-530-0011CEREZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0061CESAMET PRIOR AUTHORIZATION CRITERIA
UMC-530-0084CIMZIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0076CINRYZE PRIOR AUTHORIZATION CRITERIA
UMC-530-0120COMETRIQ PRIOR AUTHORIZATION CRITERIA
UMC-530-0183CYRAMZA PRIOR AUTHORIZATION CRITERIA
UMC-530-0168CYSTAGON PRIOR AUTHORIZATION CRITERIA
UMC-530-0158CYSTARAN PRIOR AUTHORIZATION CRITERIA
UMC-530-0131DALIRESP PRIOR AUTHORIZATION CRITERIA
UMC-530-0149DAYTRANA STEP THERAPY CRITERIA
UMC-530-0149DESOXYN STEP THERAPY CRITERIA
UMC-530-0066DESVENLAFAXINE STEP THERAPY CRITERIA
UMC-530-0126DIFICID PRIOR AUTHORIZATION CRITERIA
UMC-530-0039DIPENTUM STEP THERAPY CRITERIA
UMC-530-0208DOCERTAXEL (TAXOTERE) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0108DORYX PRIOR AUTHORIZATION CRITERIA
UMC-530-0108DOXYCYCLINE HYCLATE DELAYED RELEASE TABLETS/CAPSULES PRIOR AUTHORIZATION CRITERIA
UMC-530-0082EDARBI STEP THERAPY CRITERIA
UMC-530-0083EDARBYCLOR STEP THERAPY CRITERIA
UMC-530-0081EDLUAR STEP THERAPY CRITERIA
UMC-530-0112EGRIFTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0019ELAPRASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0011ELELYSO PRIOR AUTHORIZATION CRITERIA 
UMC-530-0132ELIDEL PRIOR AUTHORIZATION CRITERIA
UMC-530-0164ELOXATIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0085ENABLEX STEP THERAPY CRITERIA
UMC-530-0006ENBREL PRIOR AUTHORIZATION CRITERIA
UMC-530-0084ENTYVIO STEP THERAPY CRITERIA
UMC-530-0159ERBITUX PRIOR AUTHORIZATION CRITERIA
UMC-530-0135ERIVEDGE PRIOR AUTHORIZATION CRITERIA
UMC-530-0212ESBRIET PRIOR AUTHORIZATION CRITERIA
UMC-530-0027ESOMEPRAZOLE PRIOR AUTHORIZATION CRITERIA
UMC-530-0105EUFLEXXA PRIOR AUTHORIZATION CRITERIA
UMC-530-0042EXALGO STEP THERAPY CRITERIA
UMC-530-0106EXTAVIA STEP THERAPY CRITERIA
UMC-530-0020FABRAZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0142FARXIGA STEP THERAPY CRITERIA
UMC-530-0047FENTANYL TRANSMCOSAL PRIOR AUTHORIZATION CRITERIA
UMC-530-0047FENTORA PRIOR AUTHORIZATION CRITERIA
UMC-530-0066FETZIMA STEP THERAPY CRITERIA
UMC-530-0076FIRAZYR PRIOR AUTHORIZATION CRITERIA
UMC-530-0149FOCALIN XR STEP THERAPY CRITERIA
UMC-530-0015FORTEO PRIOR AUTHORIZATION CRITERIA
UMC-530-0087FORTESTA STEP THERAPY CRITERIA
UMC-530-0099GAMMAGARD PRIOR AUTHORIZATION CRITERIA
UMC-530-0099GAMMAKED PRIOR AUTHORIZATION CRITERIA
UMC-530-0099GAMUNEX- C PRIOR AUTHORIZATION CRITERIA
UMC-530-0150GATTEX (TEDUGLUTIDE [rDNA ORIGIN]) PRIOR AUTHORIZATION CRITERIA
UMC-530-0174GAZYVA PRIOR AUTHORIZATION CRITERIA
UMC-530-0105GEL-ONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0160GEMZAR PRIOR AUTHORIZATION CRITERIA
UMC-530-0039GIAZO STEP THERAPY CRITERIA
UMC-530-0166GILOTRIF PRIOR AUTHORIZATION CRITERIA
UMC-530-0113GILENYA PRIOR AUTHORIZATION CRITERIA
UMC-530-0009GLEEVEC PRIOR AUTHORIZATION CRITERIA
UMC-530-0057GRALISE PRIOR AUTHORIZATION CRITERIA
UMC-530-0163GRANIX PRIOR AUTHORIZATION CRITERIA
UMC-530-0182GRASTEK PRIOR AUTHORIZATION CRITERIA
UMC-530-0012GROWTH HORMONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0117HALAVEN PRIOR AUTHORIZATION CRITERIA
UMC-530-0211HARVONI PRIOR AUTHORIZATION CRITERIA
UMC-530-0161HERCEPTIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0184HETLIOZ PRIOR AUTHORIZATION CRITERIA
UMC-530-0099HIZENTRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0057HORIZANT PRIOR AUTHORIZATION CRITERIA
UMC-530-0016HUMIRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0105HYALGAN PRIOR AUTHORIZATION CRITERIA
UMC-530-0042HYDROMORPHONE ER STEP THERAPY CRITERIA
UMC-530-0099HYQVIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0067ICLUSIG PRIOR AUTHORIZATION CRITERIA
UMC-530-0072ILARIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0175IMBRUVICA PRIOR AUTHORIZATION CRITERIA
UMC-530-0013INCRELEX PRIOR AUTHORIZATION CRITERIA
UMC-530-0136INLYTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0081INTERMEZZO STEP THERAPY CRITERIA
UMC-530-0142INVOKANA STEP THERAPY CRITERIA
UMC-530-0118IPRIVASK PRIOR AUTHORIZATION CRITERIA
UMC-530-0152IVIG PRIOR AUTHORIZATION CRITERIA
UMC-530-0176IXEMPRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0141JAKAFI PRIOR AUTHORIZATION CRITERIA
UMC-530-0148JUXTAPID PRIOR AUTHORIZATION CRITERIA
UMC-530-0153KADCYLA PRIOR AUTHORIZATION CRITERIA
UMC-530-0076KALBITOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0134KALYDECO PRIOR AUTHORIZATION CRITERIA
UMC-530-0058KAZANO STEP THERAPY CRITERIA
UMC-530-0202KEYTRUDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0066KHEDELZA STEP THERAPY CRITERIA
UMC-530-0023KINERET PRIOR AUTHORIZATION CRITERIA
UMC-530-0058KOMBIGLYZE XR STEP THERAPY CRITERIA
UMC-530-0139KORLYM PRIOR AUTHORIZATION CRITERIA
UMC-530-0114KRYSTEXXA PRIOR AUTHORIZATION CRITERIA
UMC-530-0148KYNAMRO PRIOR AUTHORIZATION CRITERIA
UMC-530-0143KYPROLIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0027LANSOPRAZOLE STEP THERAPY CRITERIA
UMC-530-0047LAZANDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0038LESCOL XL STEP THERAPY CRITERIA
UMC-530-0065LETAIRIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0030LEUPROLIDE INJECTION PRIOR AUTHORIZATION CRITERIA
UMC-530-0038LIVALO STEP THERAPY CRITERIA
UMC-530-0127LUMIGAN STEP THERAPY CRITERIA
UMC-530-0100LUMIZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0057LYRICA STEP THERAPY & PRIOR AUTHORIZATION CRITERIA
UMC-530-0046MAXAIR STEP THERAPY CRITERIA
UMC-530-0119MAKENA PRIOR AUTHORIZATION CRITERIA
UMC-530-0146MARQIBO PRIOR AUTHORIZATION CRITERIA
UMC-530-0167MEKINIST PRIOR AUTHORIZATION CRITERIA
UMC-530-0149METHYLIN STEP THERAPY CRITERIA
UMC-530-0071MINILINK TRANSMITTER-SENSOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0108MINOCYCLINE HCl ER PRIOR AUTHORIZATION CRITERIA
UMC-530-0108MONODOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0105MONOVISC PRIOR AUTHORIZATION CRITERIA
UMC-530-0108MORGIDOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0185MYALEPT PRIOR AUTHORIZATION CRITERIA
UMC-530-0100MYOZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0053NAGLAZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0115NALFON STEP THERAPY CRITERIA
UMC-530-0115NAPRELAN STEP THERAPY CRITERIA
UMC-530-0058NESINA STEP THERAPY CRITERIA
UMC-530-0163NEULASTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0163NEUPOGEN PRIOR AUTHORIZATION CRITERIA
UMC-530-0027NEXIUM STEP THERAPY CRITERIA
UMC-530-0116NUEDEXTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0108OCUDOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0212OFEV PRIOR AUTHORIZATION CRITERIA
UMC-530-0124OLYSIO PRIOR AUTHORIZATION CRITERIA
UMC-530-0044OMNARIS STEP THERAPY CRITERIA
UMC-530-0058ONGLYZA STEP THERAPY CRITERIA
UMC-530-0004ONMEL (ITRACONAZOLE) PRIOR AUTHORIZATION
UMC-530-0047ONSOLIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0042OPANA ER STEP THERAPY CRITERIA 
UMC-530-0065OPSUMIT PRIOR AUTHORIZATION AND STEP THERAPY CRITERIA
UMC-530-0108ORACEA PRIOR AUTHORIZATION CRITERIA
UMC-530-0182ORALAIR PRIOR AUTHORIZATION CRITERIA
UMC-530-0107ORAVIG STEP THERAPY CRITERIA
UMC-530-0084ORENCIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0186ORENITRAM PRIOR AUTHORIZATION CRITERIA
UMC-530-0024ORFADIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0105ORTHOVISC PRIOR AUTHORIZATION CRITERIA
UMC-530-0058OSENI STEP THERAPY CRITERIA
UMC-530-0084OTEZLA STEP THERAPY CRITERIA
UMC-530-0187OTREXUP PRIOR AUTHORIZATON CRITERIA
UMC-530-0022OXANDRIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0042OXYMORPHONE ER STEP THERAPY CRITERIA
UMC-530-0207PACLITAXEL (TAXOL) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0008PEGASYS PRIOR AUTHORIZATION CRITERIA
UMC-530-0138PERJETA PRIOR AUTHORIZATION CRITERIA
UMC-530-0106PLEGRIDY STEP THERAPY CRITERIA
UMC-530-0154POMALYST PRIOR AUTHORIZATION CRITERIA
UMC-530-0027PREVACID SOLUTABS STEP THERAPY CRITERIA
UMC-530-0027PRILOSEC SUSPENSION PACKET STEP THERAPY CRITERIA
UMC-530-0066PRISTIQ PRIOR AUTHORIZATION/STEP THERAPY CRITERIA
UMC-530-0149PROCENTRA ORAL SOLUTION STEP THERAPY CRITERIA
UMC-530-0168PROCYSBI PRIOR AUTHORIZATION CRITERIA
UMC-530-0111PROLASTIN-C STEP THERAPY CRITERIA
UMC-530-0097PROLIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0132PROTOPIC PRIOR AUTHORIZATION CRITERIA
UMC-530-0046PROVENTIL HFA STEP THERAPY CRITERIA
UMC-530-0044QNASL STEP THERAPY CRITERIA
UMC-530-0149QUILLIVANT XR ORAL SUSPENSION STEP THERAPY CRITERIA
UMC-530-0045Q-VAR STEP THERAPY CRITERIA
UMC-530-0182RAGWITEK PRIOR AUTHORIZATION CRITERIA
UMC-530-0210RALOXIFENE AT ZERO COPAY PRIOR AUTHORIZATION
UMC-530-0156RAYOS PRIOR AUTHORIZATION CRITERIA
UMC-530-0069RECLAST PRIOR AUTHORIZATION CRITERIA
UMC-530-0075RELISTOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0084REMICADE PRIOR AUTHORIZATION CRITERIA
UMC-530-0155REVLIMID PRIOR AUTHORIZATION CRITERIA
UMC-530-0165RITUXAN PRIOR AUTHORIZATION CRITERIA
UMC-530-0056RUCONEST PRIOR AUTHORIZATION CRITERIA
UMC-530-0090SAMSCA PRIOR AUTHORIZATION CRITERIA
UMC-530-0036SANCUSO STEP THERAPY CRITERIA
UMC-530-0081SILENOR STEP THERAPY CRITERIA
UMC-530-0084SIMPONI PRIOR AUTHORIZATION CRITERIA
UMC-530-0108SOLODYN PRIOR AUTHORIZATION CRITERIA
UMC-530-0021SOMAVERT PRIOR AUTHORIZATION CRITERIA
UMC-530-0177SOVALDI PRIOR AUTHORIZATION CRITERIA
UMC-530-0115SPRIX STEP THERAPY CRITERIA
UMC-530-0067SPRYCEL PRIOR AUTHORIZATION CRITERIA
UMC-530-0084STELARA PRIOR AUTHORIZATION CRITERIA
UMC-530-0144STIVARGA PRIOR AUTHORIZATION CRITERIA
UMC-530-0172SUBOXONE AND SUBUTEX PRIOR AUTHORIZATION CRITERIA
UMC-530-0047SUBSYS PRIOR AUTHORIZATION CRITERIA
UMC-530-0105SUPARTZ PRIOR AUTHORIZATION CRITERIA
UMC-530-0204SUTENT PRIOR AUTHORIZATION CRITERIA
UMC-530-0123SYLATRON PRIOR AUTHORIZATION CRITERIA
UMC-530-0188SYLVANT PRIOR AUTHORIZATION CRITERIA
UMC-530-0051SYMLIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0005SYNAGIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0151SYNRIBO PRIOR AUTHORIZATION CRITERIA
UMC-530-0105SYNVISC-ONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0105SYNVISC PRIOR AUTHORIZATION CRITERIA
UMC-530-0169TAFINLAR PRIOR AUTHORIZATION CRITERIA
UMC-530-0200TAMOXIFEN AT ZERO COPAY PRIOR AUTHORIZATION
UMC-530-0052TANZEUM STEP THERAPY CRITERIA
UMC-530-0067TASIGNA PRIOR AUTHORIZATION CRITERIA
UMC-530-0113TECFIDERA PRIOR AUTHORIZATION CRITERIA
UMC-530-0068TEKTURNA/TEKTURNA HCT STEP THERAPY CRITERIA
UMC-530-0087TESTIM STEP THERAPY CRITERIA
UMC-530-0087TESTOSTERONE STEP THERAPY CRITERIA
UMC-530-0083TEVETEN HCT STEP THERAPY CRITERIA
UMC-530-0085TOVIAZ STEP THERAPY CRITERIA
UMC-530-0065TRACLEER PRIOR AUTHORIZATION CRITERIA
UMC-530-0127TRAVATAN-Z STEP THERAPY CRITERIA
UMC-530-0178TREANDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0052TRULICITY STEP THERAPY CRITERIA
UMC-530-0062TYKERB PRIOR AUTHORIZATION CRITERIA
UMC-530-0074TYSABRI PRIOR AUTHORIZATION CRITERIA
UMC-530-0064TYVASO PRIOR AUTHORIZATION CRITERIA
UMC-530-0068VALTURNA STEP THERAPY CRITERIA
UMC-530-0179VALCHLOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0171VELCADE PRIOR AUTHORIZATION CRITERIA
UMC-530-0133VELTIN STEP THERAPY CRITERIA
UMC-530-0064VENTAVIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0044VERAMYST STEP THERAPY CRITERIA
UMC-530-0124VICTRELIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0054VIIBRYD STEP THERAPY CRITERIA
UMC-530-0137V-GO DISPOSABLE INSULIN DELIVERY PRIOR AUTHORIZATION CRITERIA
UMC-530-0052VICTOZA STEP THERAPY CRITERIA
UMC-530-0211VIEKIRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0180VIMIZIM PRIOR AUTHORIZATION CRITERIA
UMC-530-0077VIMOVO STEP THERAPY CRITERIA
UMC-530-0087VOGELXO STEP THERAPY CRITERIA
UMC-530-0140VOTRIENT PRIOR AUTHORIZATION CRITERIA
UMC-530-0011VPRIV PRIOR AUTHORIZATION CRITERIA
UMC-530-0149VYVANSE STEP THERAPY CRITERIA
UMC-530-0128XALKORI PRIOR AUTHORIZATION CRITERIA
UMC -530-0084XELJANZ PRIOR AUTHORIZATION CRITERIA
UMC -530-0086XENAZINE PRIOR AUTHORIZATION CRITERIA
UMC -530-0097XGEVA PRIOR AUTHORIZATION CRITERIA
UMC-530-0032XOLAIR PRIOR AUTHORIZATION CRITERIA
UMC-530-0121XTANDI PRIOR AUTHORIZATION CRITERIA
UMC-530-0122YERVOY PRIOR AUTHORIZATION CRITERIA
UMC-530-0145ZALTRAP PRIOR AUTHORIZATION CRITERIA
UMC-530-0034ZAVESCA PRIOR AUTHORIZATION CRITERIA
UMC-530-0027ZEGERID STEP THERAPY CRITERIA
UMC-530-0129ZELBORAF PRIOR AUTHORIZATION CRITERIA
UMC-530-0149ZENZEDI STEP THERAPY CRITERIA
UMC-530-0044ZETONNA STEP THERAPY CRITERIA
UMC-530-0133ZIANA STEP THERAPY CRITERIA
UMC-530-0127ZIOPTAN STEP THERAPY CRITERIA
UMC-530-0115ZIPSOR STEP THERAPY CRITERIA
UMC-530-0189ZOHYDRO ER PRIOR AUTHORIZATION CRITERIA
UMC-530-0059ZOLINZA PRIOR AUTHORIZATION CRITERIA
UMC -530-0081ZOLPIMIST STEP THERAPY CRITERIA
UMC-530-0069ZOMETA PRIOR AUTHORIZATION CRITERIA
UMC-530-0036ZUPLENZ FILMSTRIPS STEP THERAPY CRITERIA
UMC-530-0203ZYDELIG PRIOR AUTHORIZATION CRITERIA
UMC-530-0190ZYKADIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0121ZYTIGA PRIOR AUTHORIZATION CRITERIA

By Drug Class:

UMC-530-00365HT3 RECEPTOR ANTAGONIST ANTI-EMETICS STEP THERAPY CRITERIA
UMC-530-0133ACNE COMBINATION STEP THERAPY CRITERIA
UMC-530-0182ALLERGY IMMUNOTHERAPY, SUBLINGUAL PRIOR AUTHORIZATION CRITERIA
UMC-530-0111ALPHA1 PROTEINASE INHIBITOR (HUMAN) STEP THERAPY CRITERIA
UMC-530-0022ANABOLIC STEROIDS PRIOR AUTHORIZATION CRITERIA
UMC-530-0083ANGIOTENSIN II RECEPTOR ANTAGONIST/ HYDROCHLOROTHIAZIDE COMBINATION STEP THERAPY CRITERIA
UMC-530-0082ANGIOTENSIN II RECEPTOR ANTAGONIST STEP THERAPY CRITERIA
UMC-530-0078BLOOD GLUCOSE TEST STRIP PRIOR AUTHORIZATION CRITERIA
UMC-530-0046BRONCHODILATOR SHORT ACTING PT STEP THERAPY CRITERIA
UMC-530-0149CENTRAL NERVOUS STIMULANTS (CNS) FOR ATTENTION DEFICIT/HYPERACTIVITY (ADHD) STEP THERAPY CRITERIA
UMC-530-0071CONTINUOUS GLUCOSE MONITORS AND SENSORS PRIOR AUTHORIZATION CRITERIA
UMC-530-0001CONTRACEPTIVES PRIOR AUTHORIZATION CRITERIA
UMC-530-0108DOXYCYCLINE/MINOCYCLINE EXTENDED RELEASE PRODUCTS PRIOR AUTHORIZATION CRITERIA
UMC-530-0058DPP IV INHIBITORS STEP THERAPY CRITERIA
UMC-530-0065ENDOTHELIN-RECEPTOR ANTAGONISTS PRIOR AUTHORIZATION CRITERIA
UMC-530-0070EXEMPT INFANT FORMULAS PRIOR AUTHORIZATION CRITERIA
UMC-530-0029FERTILITY INJECTIBLE MEDICATION PRIOR AUTHORIZATION CRITERIA
UMC-530-0011GAUCHER DISEASE MEDICATION PRIOR AUTHORIZATION CRITERIA
UMC-530-0052GLP-1 RECEPTOR AGONISTS STEP THERAPY CRITERIA
UMC-530-0211HEPATITIS C MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0076HEREDITARY ANGIOEDEMA (HAE) MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0038HMGs (STATINS) STEP THERAPY CRITERIA
UMC-530-0105HYALURONIC ACID DERIVATIVES PRIOR AUTHORIZATION CRITERIA
UMC-530-0212IDIOPATHIC PULMONARY FIBROSIS (IPF) MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0099IMMUNE GLOBULIN SUBCUTANEOUS, PRIOR AUTHORIZATION CRITERIA
UMC-530-0049IMMUNIZATIONS POLICY
UMC-530-0084IMMUNOMODULATORS IN THE TREATMENT OF INFLAMMATORY DISEASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0039INFLAMMATORY BOWEL MEDICATIONS STEP THERAPY
UMC-530-0067KINASE INHIBITORS FOR LEUKEMIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0120KINASE INHIBITORS IN THE TREATMENT OF MEDULLARY THYROID CANCER PRIOR AUTHORIZATION CRITERIA
UMC-530-0042LONG -ACTING NARCOTIC ANALGESICS
UMC-530-0033LYME DISEASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0113MULTIPLE SCLEROSIS DISEASE ORAL MODIFYING AGENTS PRIOR AUTHORIZATION CRITERIA
UMC-530-0106MULTIPLE SCLEROSIS SELF-ADMINISTERED INJECTABLES STEP THERAPY CRITERIA
UMC-530-0044NASAL CORTICOSTEROIDS STEP THERAPY CRITERIA
UMC-530-0115NSAID STEP THERAPY CRITERIA
UMC-530-0127OPHTHALMIC PROSTAGLANDIN AGONISTS STEP THERAPY CRITERIA
UMC-530-0085OVERACTIVE BLADDER MEDICATIONS STEP THERAPY CRITERIA
UMC-530-0008PEGYLATED INTERFERON ALPHA PRIOR AUTHORIZATION CRITERIA
UMC-530-0124PROTEASE INHIBITORS IN THE TREATMENT OF HEPATITIS C PRIOR AUTHORIZATION CRITERIA
UMC-530-0027PROTON PUMP INHIBITORS STEP THERAPY CRITERIA
UMC-530-0045PULMONARY ANTI-INFLAMMATORIES STEP THERAPY CRITERIA
UMC-530-0081SEDATIVE/HYPNOTIC STEP THERAPY CRITERIA
UMC-530-0066SNRI STEP THERAPY CRITERIA
UMC-530-0054SSRI STEP THERAPY CRITERIA
UMC-530-0038STATINS STEP THERAPY CRITERIA
UMC-530-0087TESTOSTERONE-TOPICAL STEP THERAPY CRITERIA
UMC-530-0069ZOLEDRONIC ACID (RECLAST/ZOMETA) INFUSION PRIOR AUTHORIZATION CRITERIA